Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$93.2M |
| 2 |
Fortive
FTV
|
+$32.4M |
| 3 |
Keurig Dr Pepper
KDP
|
+$30.9M |
| 4 |
Wynn Resorts
WYNN
|
+$24.7M |
| 5 |
GB
Global Blue Group Holding
GB
|
+$21.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equitable Holdings
EQH
|
+$22.7M |
| 2 |
FPAC.U
Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00
FPAC.U
|
+$22.4M |
| 3 |
Sherwin-Williams
SHW
|
+$21.1M |
| 4 |
Morgan Stanley
MS
|
+$12.4M |
| 5 |
Visa
V
|
+$11.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.28% |
| 2 | Consumer Discretionary | 16.32% |
| 3 | Industrials | 14.02% |
| 4 | Technology | 11.54% |
| 5 | Financials | 8.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Verizon
VZ
$205B
| $1.85M | 0.08% |
+34,654
| New | +$1.83M |
|
302
Valmont Industries
VMI
$9.38B
| $1.84M | 0.08% |
+13,300
| New | +$1.87M |
|
303
Harvard Bioscience
HBIO
$34.1M
| $1.84M | 0.08% |
35,060
+17,560
| +100% | +$986K |
|
304
Sensient Technologies
SXT
$5.73B
| $1.82M | 0.08% |
23,800
+20,090
| +542% | +$1.43M |
|
305
Lennox International
LII
$13.9B
| $1.81M | 0.08% |
8,300
+6,051
| +269% | +$1.32M |
|
306
Abercrombie & Fitch
ANF
$4.84B
| $1.81M | 0.08% |
85,700
+64,500
| +304% | +$1.56M |
|
307
FirstEnergy
FE
$26.6B
| $1.8M | 0.08% |
48,472
-111,467
| -70% | -$4.07M |
|
308
Globus Medical
GMED
$11.7B
| $1.8M | 0.08% |
31,700
-47,878
| -60% | -$2.52M |
|
309
Allstate
ALL
$64.2B
| $1.8M | 0.08% |
18,200
-2,398
| -12% | -$234K |
|
310
HealthEquity
HQY
$8.81B
| $1.79M | 0.08% |
19,000
+9,000
| +90% | +$775K |
|
311
Ryman Hospitality Properties
RHP
$8.86B
| $1.79M | 0.08% |
+20,800
| New | +$1.78M |
|
|
BIG
312
DELISTED
Big Lots, Inc.
BIG
| $1.78M | 0.08% |
+42,500
| New | +$1.87M |
|
313
Bristol-Myers Squibb
BMY
$137B
| $1.76M | 0.08% |
28,400
+14,149
| +99% | +$840K |
|
314
Lam Research
LRCX
$393B
| $1.71M | 0.08% |
+113,000
| New | +$1.93M |
|
315
McKesson
MCK
$100B
| $1.71M | 0.08% |
12,900
+8,762
| +212% | +$1.14M |
|
316
Cadence Design Systems
CDNS
$87.9B
| $1.71M | 0.08% |
37,690
+13,121
| +53% | +$597K |
|
|
LOXO
317
DELISTED
Loxo Oncology, Inc
LOXO
| $1.71M | 0.08% |
10,000
| – | – |
|
318
Autodesk
ADSK
$53.6B
| $1.7M | 0.08% |
+10,900
| New | +$1.54M |
|
319
Enovis
ENOV
$1.5B
| $1.7M | 0.08% |
+27,307
| New | +$1.56M |
|
320
NetApp
NTAP
$37.7B
| $1.69M | 0.08% |
+19,700
| New | +$1.63M |
|
321
Rockwell Automation
ROK
$48.5B
| $1.69M | 0.08% |
+9,000
| New | +$1.61M |
|
322
Establishment Labs
ESTA
$2.17B
| $1.69M | 0.08% |
+70,000
| New | +$1.8M |
|
|
CARM
323
DELISTED
Carisma Therapeutics
CARM
| $1.67M | 0.07% |
+38,905
| New | +$1.52M |
|
324
HEICO Corp
HEI
$49.6B
| $1.67M | 0.07% |
+18,028
| New | +$1.48M |
|
325
Sempra
SRE
$54.2B
| $1.65M | 0.07% |
+29,040
| New | +$1.68M |
|
Similar funds
Steve Schonfeld's Q3 2018 Portfolio in Review
As of Q3 2018, Steve Schonfeld held 1,145 positions worth $2.25B, up 22% from $1.84B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $2.31B of net new capital in Q3 2018, opening 406 new positions and adding to 187 existing holdings. Its largest new stake was Fortive: 632,433 shares worth $33.6M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Equitable Holdings, an estimated $22.7M trimmed.
- Steve Schonfeld's largest Q3 2018 buy was Fortive: 632,433 shares worth $33.6M.
- Steve Schonfeld added most to State Street SPDR S&P 500 ETF Trust in Q3 2018, an estimated $93.2M increase.
- Steve Schonfeld's biggest Q3 2018 reduction was Equitable Holdings, cutting an estimated $22.7M.
- Steve Schonfeld fully exited Far Point Acquisition Corporation Units, each consisting of one share of Class A common stock, $0.00 in Q3 2018, selling an estimated $22.4M.
- Steve Schonfeld's ten largest holdings make up 15% of its $2.25B portfolio in Q3 2018.
- Steve Schonfeld opened 406 new positions and closed 367 in Q3 2018.
- Steve Schonfeld's portfolio value rose 22% quarter-over-quarter to $2.25B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.